Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2007 1
2009 1
2011 1
2014 2
2015 3
2017 2
2018 3
2019 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Heart Rate Extraction in a Headphone Using Infrared Thermometry.
de Graaf G, Kuratomi Cruz D, Haartsen JC, Hooijschuur F, French PJ. de Graaf G, et al. Among authors: haartsen jc. IEEE Trans Biomed Circuits Syst. 2019 Oct;13(5):1052-1062. doi: 10.1109/TBCAS.2019.2930312. Epub 2019 Jul 23. IEEE Trans Biomed Circuits Syst. 2019. PMID: 31352351
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells.
Gresle MM, Jordan MA, Stankovich J, Spelman T, Johnson LJ, Laverick L, Hamlett A, Smith LD, Jokubaitis VG, Baker J, Haartsen J, Taylor B, Charlesworth J, Bahlo M, Speed TP, Brown MA, Field J, Baxter AG, Butzkueven H. Gresle MM, et al. Among authors: haartsen j. Life Sci Alliance. 2020 Jun 9;3(7):e202000650. doi: 10.26508/lsa.202000650. Print 2020 Jul. Life Sci Alliance. 2020. PMID: 32518073 Free PMC article.
Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery.
De Meijer L, Merlo D, Skibina O, Grobbee EJ, Gale J, Haartsen J, Maruff P, Darby D, Butzkueven H, Van der Walt A. De Meijer L, et al. Among authors: haartsen j. Mult Scler J Exp Transl Clin. 2018 Dec 10;4(4):2055217318815513. doi: 10.1177/2055217318815513. eCollection 2018 Oct-Dec. Mult Scler J Exp Transl Clin. 2018. PMID: 30559973 Free PMC article.
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients.
Dwyer CM, Jokubaitis VG, Stankovich J, Baker J, Haartsen J, Butzkueven H, Cartwright A, Shuey N, Fragoso YD, Rath L, Skibina O, Fryer K, Butler E, Coleman J, MacIntrye J, Macdonell R, van der Walt A. Dwyer CM, et al. Among authors: haartsen j. Ther Adv Neurol Disord. 2021 Apr 16;14:1756286421998915. doi: 10.1177/1756286421998915. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33948117 Free PMC article.
Fingolimod after natalizumab and the risk of short-term relapse.
Jokubaitis VG, Li V, Kalincik T, Izquierdo G, Hodgkinson S, Alroughani R, Lechner-Scott J, Lugaresi A, Duquette P, Girard M, Barnett M, Grand'Maison F, Trojano M, Slee M, Giuliani G, Shaw C, Boz C, Spitaleri DL, Verheul F, Haartsen J, Liew D, Butzkueven H; MSBase Study Group. Jokubaitis VG, et al. Among authors: haartsen j. Neurology. 2014 Apr 8;82(14):1204-11. doi: 10.1212/WNL.0000000000000283. Epub 2014 Mar 7. Neurology. 2014. PMID: 24610329 Free PMC article.
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, Purcell AW, Laverick L, Petzold A, Lucas RM, Van der Walt A, Prime H, Morris DR, Taylor BV; Ausimmune Consortium, Shaw G, Butzkueven H. Gresle MM, et al. Among authors: haartsen j. J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1209-13. doi: 10.1136/jnnp-2013-306789. Epub 2014 Mar 17. J Neurol Neurosurg Psychiatry. 2014. PMID: 24639436
Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod.
Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Sánchez-Menoyo JL, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators. Fragoso YD, et al. Among authors: haartsen j. Mult Scler Relat Disord. 2018 Jan;19:105-108. doi: 10.1016/j.msard.2017.11.018. Epub 2017 Nov 22. Mult Scler Relat Disord. 2018. PMID: 29182993
Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS.
Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, Lechner-Scott J, McGuigan C, Spach K, Chen C, Fam S, Wu F, Miller C. Chan A, et al. Among authors: haartsen j. Neurol Clin Pract. 2020 Dec;10(6):510-519. doi: 10.1212/CPJ.0000000000000800. Neurol Clin Pract. 2020. PMID: 33510947 Free PMC article.
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)].
Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Menoyo JLS, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators. Fragoso YD, et al. Among authors: haartsen j. Mult Scler Relat Disord. 2018 May;22:166. doi: 10.1016/j.msard.2018.02.025. Epub 2018 Feb 24. Mult Scler Relat Disord. 2018. PMID: 29807821 No abstract available.
Association of plasma levels of Protein S with disease severity in multiple sclerosis.
Ma GZ, Giuffrida LL, Gresle MM, Haartsen J, Laverick L, Butzkueven H, Field J, Binder MD, Kilpatrick TJ. Ma GZ, et al. Among authors: haartsen j. Mult Scler J Exp Transl Clin. 2015 Jul 24;1:2055217315596532. doi: 10.1177/2055217315596532. eCollection 2015 Jan-Dec. Mult Scler J Exp Transl Clin. 2015. PMID: 28607700 Free PMC article.
17 results